CoChat

Modulation of immune checkpoint molecule expression in mantle cell lymphoma

Open access

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Abstract

Mantle cell lymphoma (MCL) is an aggressive B-cell malignancy for which novel therapeutics with improved efficacy are greatly needed. To provide support for clinical immune checkpoint blockade, we comprehensively evaluated the expression of therapeutically targetable immune checkpoint molecules on primary MCL cells. MCL cells showed constitutive expression of Programmed Death 1 (PD-1) and Programmed Death Ligand 1 (PD-L1), variable CD200, absent PD-L2, Lymphocyte Activation Gene 3 (LAG-3), and Cytotoxic T-cell Associated Protein 4 (CTLA-4). Effector cells from MCL patients expressed PD-1. Co-culture of MCL cells with T-cells induced PD-L1 surface expression, a phenomenon regulated by IFNγ and CD40:CD40L interaction. Induction of PD-L1 was attenuated by concurrent treatment with ibrutinib or duvelisib, suggesting BTK and PI3K are important mediators of PD-L1 expression. Overall, our data provide further insight into the expression of checkpoint molecules in MCL and support the use of PD-L1 blocking antibodies in MCL patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/10428194.2019.1569231

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 48 references

Research works printed but not linked: 1

  1. Winter D,. C f J Using the Student’s “t”-test with extremely small sample sizes. Pract. Assess Res Eval. 2013; 18: 1– 12.

Cited by

See all 31

Metadata

Authors
Harrington, B. K., Wheeler, E., Hornbuckle, K., Shana’ah, A. Y., Youssef, Y., Smith, L., Hassan II, Q., Klamer, B., Zhang, X., Long, M., Baiocchi, R. A., Maddocks, K., Johnson, A. J., Byrd, J. C., & Alinari, L.
Affiliations
  • Michigan State University (US)
  • The Ohio State University (US)
  • Medical Scientist Training Program, The Ohio State University, Columbus, OH, USA;
  • Janssen Biotech Inc., Horsham, PA, USA
Corresponding author
Alinari, Lapo
Venue
Leukemia & Lymphoma
Published
2019-03-01
Volume
60
Issue
10
Pages
2498-2507
ISSN
  • 1026-8022 (ISSN-L)
  • 1042-8194
  • 1029-2403
OpenAlex
W2918733328
Cited by
31
References
48
Citations by year
2025: 4 · 2024: 4 · 2023: 3 · 2022: 7 · 2021: 5 · 2020: 6 · 2019: 2
FWCI
3.67
Type
journal article
Language
en
Open access
Locations
  • Leukemia & lymphoma/Leukemia and lymphoma (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • NIH NCI (T32CA009338)
  • CLL Research Consortium (P01 CA081534)
  • OSU Comprehensive Cancer Center (P30 CA016058)
  • Pelotonia Graduate Fellowship
  • CCTS Davis-Bremer Scholar Award
  • D. Warren Brown Foundation
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords
mantle cell lymphoma, immune checkpoint molecules, PD-1, PD-L1, CD200, PD-L2, LAG-3, CTLA-4, T cell co-culture, interferon-gamma, CD40-CD40L interaction, ibrutinib, duvelisib, BTK inhibition, PI3K inhibition, PD-L1 blockade, B-cell malignancies
MeSH terms
Humans, Receptors, Antigen, B-Cell, Transcription, Genetic, Biomarkers, Tumor, Signal Transduction, Gene Expression Regulation, Neoplastic, T-Lymphocyte Subsets, Lymphoma, Mantle-Cell, B7-H1 Antigen, CTLA-4 Antigen, Programmed Cell Death 1 Receptor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Modulation of immune checkpoint molecule expression in mantle cell lymphoma. https://app.cochat.ai/papers/10.1080/10428194.2019.1569231
The paper
Harrington, B. K., Wheeler, E., Hornbuckle, K., Shana’ah, A. Y., Youssef, Y., Smith, L., Hassan II, Q., Klamer, B., Zhang, X., Long, M., Baiocchi, R. A., Maddocks, K., Johnson, A. J., Byrd, J. C., & Alinari, L. (2019). Modulation of immune checkpoint molecule expression in mantle cell lymphoma. Leukemia & Lymphoma. https://doi.org/10.1080/10428194.2019.1569231

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.